Literature DB >> 15274029

Association of the dopamine transporter gene (DAT1) core promoter polymorphism -67T variant with schizophrenia.

N Khodayari1, M Garshasbi, F Fadai, A Rahimi, L Hafizi, A Ebrahimi, H Najmabadi, Mina Ohadi.   

Abstract

Dysfunction of the central dopaminergic neurotransmission has been suggested to play an important role in the etiology of schizophrenia. The dopamine transporter (DAT1) mediates the active reuptake of dopamine from the synapses and thereby plays a key role in the regulation of the dopaminergic neurotransmission. In this study, we sought to determine the possible association of the DAT1 gene core promoter polymorphism -67A/T with schizophrenia in a case/control study. The allele and genotype frequencies of the polymorphism were studied in 100 patients and 100 controls, which were matched on the basis of sex, age, and ethnicity. The genotype frequencies in the patients group were as follows: AA 29%; AT 59%; TT 12% versus the genotype frequencies in the control group: AA 57%; AT 38%; TT 5% [chi2 = 16.54, df = 2, OR = 2.25 (95% CI 1.46-3.45, P < or = 0.0003]. For the first time, these findings provide tentative evidence for the contribution of the DAT1 gene core promoter polymorphism to the etiopathophysiology of schizophrenia at least in the Iranian male population that we studied. Replication studies of independent samples and family-based association studies are necessary to further evaluate the significance of our findings. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15274029     DOI: 10.1002/ajmg.b.30067

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  11 in total

1.  Lack of association between the -839C/T polymorphism in the SLC6A3 gene promoter and schizophrenia in the Iranian population.

Authors:  Hamid Galehdari; Shiva Hosseini; Ali Mohammad Foroughmand; Mohsen Musaviun; Saeedreza Khatami; Atefeh Pooryasin; Tahereh Ajam; Maryam Haidari
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

2.  A Meta-analysis of the Association Between SLC6A3 Gene Polymorphisms and Schizophrenia.

Authors:  Feng-Ling Xu; Mei Ding; Xue Wu; Yong-Ping Liu; Xi Xia; Jun Yao; Bao-Jie Wang
Journal:  J Mol Neurosci       Date:  2019-08-22       Impact factor: 3.444

3.  Family-based study of markers at the 5'-flanking region of the human dopamine transporter gene reveals potential association with schizophrenic psychoses.

Authors:  Gerald Stöber; Julia Sprandel; Burkhard Jabs; Bruno Pfuhlmann; Kerstin Möller-Ehrlich; Michael Knapp
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

4.  Ventral midbrain correlation between genetic variation and expression of the dopamine transporter gene in cocaine-abusing versus non-abusing subjects.

Authors:  Yanhong Zhou; Sharon K Michelhaugh; Carl J Schmidt; Jun S Liu; Michael J Bannon; Zhicheng Lin
Journal:  Addict Biol       Date:  2011-10-26       Impact factor: 4.280

5.  Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder.

Authors:  Tiffany A Greenwood; Eun-Jeong Joo; Tatyana Shekhtman; A Dessa Sadovnick; Ronald A Remick; Paul E Keck; Susan L McElroy; John R Kelsoe
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-12-19       Impact factor: 3.568

6.  DNA methylation and expression profiles of the brain-derived neurotrophic factor (BDNF) and dopamine transporter (DAT1) genes in patients with schizophrenia.

Authors:  Dor Mohammad Kordi-Tamandani; Roya Sahranavard; Adam Torkamanzehi
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

7.  Functional analysis of upstream common polymorphisms of the dopamine transporter gene.

Authors:  Mikhil N Bamne; Michael E Talkowski; Kodavali V Chowdari; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2009-03-09       Impact factor: 9.306

8.  Increased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean Cohorts.

Authors:  James L Kennedy; Nian Xiong; Jinlong Yu; Clement C Zai; Jennie G Pouget; Jie Li; Kefu Liu; Hong Qing; Tao Wang; Eden Martin; Deborah L Levy; Zhicheng Lin
Journal:  Schizophr Bull       Date:  2015-12-26       Impact factor: 9.306

9.  A network of dopaminergic gene variations implicated as risk factors for schizophrenia.

Authors:  Michael E Talkowski; George Kirov; Mikhil Bamne; Lyudmila Georgieva; Gonzalo Torres; Hader Mansour; Kodavali V Chowdari; Vihra Milanova; Joel Wood; Lora McClain; Konasale Prasad; Brian Shirts; Jianping Zhang; Michael C O'Donovan; Michael J Owen; Bernie Devlin; Vishwajit L Nimgaonkar
Journal:  Hum Mol Genet       Date:  2007-11-27       Impact factor: 6.150

Review 10.  Dopamine genes and schizophrenia: case closed or evidence pending?

Authors:  Michael E Talkowski; Mikhil Bamne; Hader Mansour; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.